While all treatments demonstrated an overall trend toward reduced p-AKT levels, the temporal progression of these effects exhibited cell line-specific patterns.
← all excerpts
Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.
1
—
—